Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1

Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1

The aim of this study was to investigate the effect of Bifidobacterium lactis Probio-M8 on glucolipid metabolism and gut microbiota (GM) composition in type 2 diabetes mellitus (T2DM) mice. The glucolipid metabolic profiles were analyzed. The 16S rRNA gene sequencing was employed to investigate GM....

Full description

Bibliographic Details
Main Authors: Chen Ye, Zhao Yaxin, Shen Xin, Zhao Feiyan, Qi Jinxin, Zhong Zhi, Li Dongmei
Format: Article
Language:English
Published: De Gruyter 2022-12-01
Series:Open Medicine
Subjects:
probio-m8
type 2 diabetes mellitus
fxr-cyp7a1
glucolipid metabolism
gut microbiota
Online Access:https://doi.org/10.1515/med-2022-0576

Internet

https://doi.org/10.1515/med-2022-0576

Similar Items